6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function — studies in normal humans (original) (raw)

References

  1. Goldstein DS, Chang PC, Eisenhofer G_et al._ Positron emission tomographic imaging of cardiac sympathetic innervation and function.Circulation 1990;81: 1606–1621.
    Google Scholar
  2. Goldstein DS, Eisenhofer G, Dunn BB_et al._ Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans.J Am Coll Cardiol 1993;22: 1961–1971.
    Google Scholar
  3. Rutgers M, Tytgat GA, Verwijs-Janssen M, Buitenhuis C, Voute PA, Smets LA. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.Int J Cancer 1993;54: 290–295.
    Google Scholar
  4. Ding YS, Fowler JS, Dewey SL_et al._ Comparison of high specific activity (−) and (+)-6-[18F]fluoronoradrenaline and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine.J Nucl Med 1993;34: 619–629.
    Google Scholar
  5. Fowler JS, Ding YS, Volkow ND_et al._ PET studies of cocaine inhibition of myocardial noradrenaline uptake.Synapse 1994;16: 312–317.
    Google Scholar
  6. Chiueh CC, Zukowska-Grojec Z, Kirk KL Kopin IJ. 6-Fluorocatecholamines as false adrenergic neurotransmitters.J Pharmacol Exp Ther 1983;225: 529–533.
    Google Scholar
  7. Eisenhofer G, Hovevey-Sion D, Kopin IJ_et al._ Neuronal uptake and metabolism of 2-and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.Pharmacol Exp Ther 1989;248: 419–427.
    Google Scholar
  8. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and noradrenaline spillover in normal volunteers.Am J Physiol 1991;260: R142-R147.
    Google Scholar
  9. Goldstein DS, Zimlichman R, Stull R, Keiser HR, Kopin IJ. Estimation of intrasynaptic noradrenaline concentrations in humans.Hypertension 1986;8: 471–475.
    Google Scholar
  10. Szabo B, Schultheiss A. Desipramine inhibits sympathetic nerve activity in the rabbit.Naunyn-Schmiedeberg's Arch Pharmacol 1990;342: 469–476.
    Google Scholar
  11. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits.Am J Physiol 1991;260: R824-R832.
    Google Scholar
  12. Finberg J, Dibner-Dunlap M, Yuih SN, Thames MD. Effects of desipramine hydrochloride on peripheral sympathetic nerve activity.Am J Physiol 1990;258: R876-R882.
    Google Scholar
  13. Esler MD, Wallin G, Dorward PK_et al._ Effects of desipramine on sympathetic nerve firing and noradrenaline spillover to plasma in humans.Am J Physiol 1991;260: R817-R823.
    Google Scholar
  14. Eisenhofer G, Esler MD, Meredith IT_et al._ Sympathetic nervous function in the human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and noradrenaline.Circulation 1992;85: 1775–1785.
    Google Scholar
  15. Goldstein DS, Nurnberger J, Jr, Simmons S, Gershon ES, Polinsky R, Keiser HR. Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man.Life Sci 1983;32: 1057–1063.
    Google Scholar
  16. Dunn BB, Channing MA, Adams HR, Goldstein DS, Kirk KL, Kiesewetter DO. A single column, rapid quality control procedure for 6-[18F]fluoro-L-dopa and 6-[18F]fluorodopamine PET imaging agents.Int J Rad Appl Instrum [B] 1991;18: 209–213.
    Google Scholar
  17. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.J Chromatogr B Biomed Appl 1994;653: 131–138.
    Google Scholar
  18. Goldstein DS, Brush JE, Jr, Eisenhofer G, Stull R, Esler M.In vivo measurement of neuronal uptake of noradrenaline in the human heart.Circulation 1988;78: 41–48.
    Google Scholar
  19. Goldstein DS, Grossman E, Tamrat M_et al._ Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine.J Hypertens 1991;9: 417–423.
    Google Scholar
  20. Hovevey-Sion D, Eisenhofer G, Kopin IJ_et al._ Metabolic fate of injected radiolabelled dopamine and 2-fluorodopamine in rats.Neuropharmacology 1990;29: 881–887.
    Google Scholar
  21. Goldstein DS, Zimlichman R, Stull R_et al._ Measurement of regional neuronal removal of noradrenaline in man.J Clin Invest 1985;76: 15–21.
    Google Scholar
  22. Goldstein DS, Horwitz D, Keiser HR, Polinsky RJ, Kopin IJ. Plasma I-[3H]noradrenaline, d-[14C]noradrenaline, and d,I-[3H]isoproterenol kinetics in essential hypertension.J Clin Invest 1983;72: 1748–1758.
    Google Scholar
  23. Chang PC, Szemeredi K, Grossman E, Kopin IJ, Goldstein DS. Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.J Pharmacol Exp Ther 1990;255: 809–817.
    Google Scholar
  24. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.Circulation 1986;88: 388–394.
    Google Scholar
  25. Garty M, Deka-Starosta A, Chang PC_et al._ Plasma levels of catechols during reflexive changes in sympathetic nerve activity.Neurochem Res 1989;14: 523–531.
    Google Scholar
  26. Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ. Plasma dihydroxyphenylglycol and the intraneuronal disposition of noradrenaline in humans.J Clin Invest 1988;81: 213–220.
    Google Scholar
  27. Deka-Starosta A, Garty M, Zukowska-Grojec Z, Keiser HR, Kopin IJ, Goldstein DS. Renal sympathetic nerve activity and noradrenaline release in rats.Am J Physiol 1989;257: R229-R236.
    Google Scholar
  28. Eisenhofer G, Cox HS, Esler MD. Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits.J Auton Nerv Sys 1991;32: 217–232.
    Google Scholar
  29. Graefe KH, Bonisch H. The transport of amines across the axonal membranes of nonadrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N, eds.Catecholamines I. New York: Springer-Verlag, 1988; 193–245.
    Google Scholar
  30. Iversen, L.L.The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge: Cambridge University Press, 1967.
    Google Scholar
  31. Mann GE, Yudilevich DL. Rapid transcapillary exchange and unidirectional neuronal uptake of noradrenaline in the perfused rabbit heart.J Physiol (Lond) 1984;348: 589–600.
    Google Scholar
  32. Mertes PM, Carteaux JP, Jaboin Y_et al._ Estimation of myocardial interstitial noradrenaline release after brain death using cardiac microdialysis.Transplantation 1994;57: 371–377.
    Google Scholar
  33. Kopin IJ, Breese GR, Krauss KR, Weise VK. Selective release of newly synthesized noradrenaline from the cat spleen during sympathetic nerve stimulation.J Pharmacol Exp Ther 1968;161: 271–278.
    Google Scholar
  34. Musacchio JM, Weise VK, Kopin IJ. Mechanism of noradrenaline binding.Nature 1965;205: 606–607.
    Google Scholar
  35. Musacchio JM, Kopin IJ, Weise VK. Subcellular distribution of some sympathomimetic amines and their β-hydroxylated derivatives in the rat heart.J Pharmacol Exp Ther 1965;148: 22–28.
    Google Scholar
  36. Eisenhofer G, Goldstein DS, Ropchak TG, Nguyen HQ, Keiser HR, Kopin IJ. Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol.J Auton Nerv Syst 1988;24: 1–14.
    Google Scholar

Download references